Cell-based fuzzy metrics enhance high-content screening (HCS) assay robustness.
about
Identifying and quantifying heterogeneity in high content analysis: application of heterogeneity indices to drug discoveryFlow Cytometry: Impact on Early Drug DiscoveryDesigning drugs that overcome antibacterial resistance: where do we stand and what should we do?A novel high-content analysis tool reveals Rab8-driven cytoskeletal reorganization through Rho GTPases, calpain and MT1-MMP.ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer.Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer.
P2860
Cell-based fuzzy metrics enhance high-content screening (HCS) assay robustness.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cell-based fuzzy metrics enhance high-content screening (HCS) assay robustness.
@en
Cell-based fuzzy metrics enhance high-content screening
@nl
type
label
Cell-based fuzzy metrics enhance high-content screening (HCS) assay robustness.
@en
Cell-based fuzzy metrics enhance high-content screening
@nl
prefLabel
Cell-based fuzzy metrics enhance high-content screening (HCS) assay robustness.
@en
Cell-based fuzzy metrics enhance high-content screening
@nl
P2093
P2860
P50
P356
P1476
Cell-based fuzzy metrics enhance high-content screening (HCS) assay robustness.
@en
P2093
Alberto Torres
Alvaro Salmerón
Ana M Gonzalez
Carlos M Alaíz
Hind Azegrouz
Pedro Nevado
Teijo Pellinen
P2860
P304
P356
10.1177/1087057113501554
P577
2013-09-17T00:00:00Z